| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/2005 | CN1210053C Immunologic function excitant for treating AIDS |
| 07/13/2005 | CN1210050C Medicine for treating bacterial vaginal disease |
| 07/13/2005 | CN1210048C Gingko leaf drop pill |
| 07/13/2005 | CN1210045C Medicine for curing diabetes |
| 07/13/2005 | CN1210042C Polymer and methods of formulating same |
| 07/13/2005 | CN1210041C Complex external medicine for treating acne |
| 07/13/2005 | CN1210040C Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
| 07/13/2005 | CN1210039C Total sanchinoside and ferulic acid composition for treating cardio-cerebral vascular disease and diabetes and its use |
| 07/13/2005 | CN1210038C Application of N-acetylglucosamine in the preparation of medicine for treating viscera injure due to toxication from poison and medicine |
| 07/13/2005 | CN1210037C Glucosamine and egg for reducing inflammation |
| 07/13/2005 | CN1210036C Novel usage of Aspirin-DL-Lysine |
| 07/13/2005 | CN1210035C Complex external medicine for treating psoriasis |
| 07/13/2005 | CN1210034C Medicinal composition for treating psoriasis |
| 07/13/2005 | CN1210033C Immunodepressive medicine and its preparing process and application |
| 07/13/2005 | CN1210032C Parenteral formulations comprising carbamazepine or its derivatives |
| 07/13/2005 | CN1210031C Injectable slow-releasing naltrexone microsphere compositions |
| 07/13/2005 | CN1210030C Antimicrobial composition and method for producing same |
| 07/13/2005 | CN1210029C Pharmaceutical use for piperine and method for cosmetically promoting the natural coloration of the skin |
| 07/13/2005 | CN1210028C Aqueous liquid preparation |
| 07/13/2005 | CN1210027C Pharmaceutical compositions for ulcer and application thereof |
| 07/13/2005 | CN1210026C Melatonin two-layer release-controlled tablet and preparing process thereof |
| 07/13/2005 | CN1210025C Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
| 07/13/2005 | CN1210024C Crytotanshinone for preventing and delaying early senile dementia |
| 07/13/2005 | CN1210023C Carboplatin precursor liposome injection and preparing process thereof |
| 07/13/2005 | CN1210022C Dichlofenac sodium slow-releasing preparation and its preparation method |
| 07/13/2005 | CN1210020C Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
| 07/13/2005 | CN1210017C Novel tiotropiumonium-containing inhalation powder |
| 07/12/2005 | US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 07/12/2005 | US6916942 Process for the preparation of C-4 carbonate taxanes |
| 07/12/2005 | US6916941 Crystallization fromn solutions; antidepressant |
| 07/12/2005 | US6916937 For ishcemia/stroke therapy; calcium-activated potassium channel modulators |
| 07/12/2005 | US6916935 Losartan potassium synthesis |
| 07/12/2005 | US6916927 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 07/12/2005 | US6916926 Process for the preparation of (±) 1-3-dioxolanes and the optical resolution thereof |
| 07/12/2005 | US6916923 Method for synthesizing pyrazolobenzodiazepines |
| 07/12/2005 | US6916922 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product |
| 07/12/2005 | US6916921 Steroid being specifically characterized by amino nitrogen bonded to C17 of the steroid skeleton via a spacer A ( A= substituted or unsubstitued methylene or ethylene group); stimulates meiosis in human oocytes |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916857 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 07/12/2005 | US6916852 Vasoconstriction of arteries by administering to opiate receptor agonist and cyclooxygenase inhibitor; prophylaxis of hypotension |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916849 Lowering the total amount of cholesterol in the blood using mixture of pravastatin and one or more vitamins selected from riboflavins, d-alpha-tocopherols, ascorbic acids and inositol hexanicotinate |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916847 Anticoagulants; thrombosis; cardiovascular disorders |
| 07/12/2005 | US6916845 Administering icariin for sexual disorders |
| 07/12/2005 | US6916844 Hydroxy pyranone derivative and preparation method thereof |
| 07/12/2005 | US6916843 Prevention cell damage due oxygen toxicity by administering epoxyeicosatrienoic acids and/or metabolites, from cytochrome-P450 monooxygenase enzyme ststem |
| 07/12/2005 | US6916840 Spla2 inhibitors |
| 07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/12/2005 | US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors |
| 07/12/2005 | US6916836 Compounds and methods for use thereof in the treatment of viral infections |
| 07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916832 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 07/12/2005 | US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 07/12/2005 | US6916829 Method for enhancing mutant enzyme activity in gaucher disease |
| 07/12/2005 | US6916828 Irritiable bowel syndrome; respiartory system disorders; antihistamines; gastrointestinal disorders |
| 07/12/2005 | US6916826 Substituted imidazo[1,2-a]pyridine derivatives |
| 07/12/2005 | US6916825 Alkylated imidazopyridine derivatives |
| 07/12/2005 | US6916824 Methods of treating cataracts and diabetic retinopathy with tricyclic pyrones |
| 07/12/2005 | US6916823 Method of treatment of dopamine-related dysfunction |
| 07/12/2005 | US6916822 For preventive and/or therapeutic treatment of nerve system diseases including schizophrenia, depression, cerebral apoplexy, epilepsy, Alzheimer's disease, and Parkinson's disease |
| 07/12/2005 | US6916821 Central nervous system disorders; Down's syndrome; autism |
| 07/12/2005 | US6916820 Neurotrophic substituted pyrimidines |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916818 Nitrogen compounds such as 1-(1-Naphthalenesulfonyl)-3-(octa-hydro-4-quinolizinyl)-1H-5-azaindole, used as serotonin receptor antagonists for prophylaxis of psychological disorders |
| 07/12/2005 | US6916817 Inhibitors of metalloproteinases |
| 07/12/2005 | US6916815 C-6 modified indazolylpyrrolotriazines |
| 07/12/2005 | US6916814 Methods of treating cytokine mediated diseases |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916811 Adenosine A2a receptor antagonists |
| 07/12/2005 | US6916810 αν integrin receptor antagonists |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916808 2-thio-4h-3, 1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 07/12/2005 | US6916807 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/12/2005 | US6916805 Therapeutic agents for treating or preventing disease states in mammals characterized by abnormal thrombosis |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916803 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 07/12/2005 | US6916802 Synthase inhibitors for lowering glycosphingolipid levels; anticancer agents; for treatment of Gaucher's disease |
| 07/12/2005 | US6916801 Bactericides, antibiotic |
| 07/12/2005 | US6916800 Gelatinase inhibitors; anticancer agents |
| 07/12/2005 | US6916799 Antiinflammatory agents; respiratory system disorders |
| 07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
| 07/12/2005 | US6916796 Producing a blunted glycemic response in a diabetic patient by administering pullulan |
| 07/12/2005 | US6916795 Energy-protective composition comprising adenosine phosphates |
| 07/12/2005 | US6916794 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 07/12/2005 | US6916793 Treating tumor cells with a selenium prodrug lyase and a selenium-containing prodrug such as selenocysteine, selenohomocysteine, selenomethionine or selenoethionine. |
| 07/12/2005 | US6916791 Androgen glycosides useful as contraceptives, for increasing muscle mass, and treatment of a hypogonadal disorder, androgen deficiency, sexual dysfunction and osteoporosis |
| 07/12/2005 | US6916788 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/12/2005 | US6916660 Fluorescent sensor compounds for detecting saccharides |
| 07/12/2005 | US6916653 Ribozymal nucleic acid |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916627 ATM kinase compositions and methods |
| 07/12/2005 | US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916487 Antiemetic, dermal penetration enhancer of a safe skin-tolerant sunscreen ester and volatile liquids |
| 07/12/2005 | US6916486 Mixture of analgesic hormones, skin penetration and sunscreen agents |
| 07/12/2005 | US6916485 Mixture of protein, hydrophilic polymer, group 1a alkyl sulfate and sugar |
| 07/12/2005 | US6916484 Sugars and sugar alcohols as isotonizing agents and has < 10 ppb of iron |
| 07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |